Since the level of CYP2A13, but not CYP2A6, was correlated with lung microsomal NNK metabolic activity, it was speculated that people with relatively high levels of CYP2A13 expression are likely to have an increased risk of developing smoking-related lung cancer. The gene discussed is CYP2A6; the disease is lung cancer.